Finance

Beta
Lists
XENE:NASDAQ
Xenon Pharmaceuticals Inc
$56.78
+2.16%
(+1.20) 1D
$57.91
+1.99% (+1.13)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XENE...
Open
$55.40
High
$57.14
Low
$55.28
Mkt. cap
5.49B
Avg. vol.
1.35M
Volume
94.00
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
Open
$55.40
High
$57.14
Low
$55.28
Mkt. cap
5.49B
Avg. vol.
1.35M
Volume
94.00
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
News stories
From sources across the web
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitexenon-pharma.com
Analyst ratings
Based on 11 analysts giving stock ratings to XENE in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for XENE in the last 3 months.
Highest
Current $56.78
$86.00 (+51.46%)
Average
$75.77 (+33.44%)
Lowest
$63.00 (+10.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
$63.00
+11%
06/22/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
$69.00
+21.5%
06/01/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$82.00
+44.4%
05/27/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$80.00
+40.9%
05/08/2026
Laura Chico
Wedbush
Buy
Maintained
$63.00
+11%
05/08/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$82.00
+44.4%
05/07/2026
Serge Belanger
Needham
Buy
Maintained
$78.00
+37.4%
05/08/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$74.00
+30.3%
05/08/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
05/07/2026
Myles Minter
William Blair
Buy
Reiterated
$80.65
+42%
05/08/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$86.00
+51.5%
05/08/2026
David Martin PhD
Bloom Burton
Buy
Maintained
$74.00
+30.3%
03/09/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$90.00
+58.5%
03/09/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$75.00
+32.1%
03/10/2026
David Hoang
Deutsche Bank
Buy
Maintained
$90.00
+58.5%
03/10/2026
Andrew Tsai
Jefferies
Buy
Reiterated
$100.00
+76.1%
03/09/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
$97.00
+70.8%
03/09/2026
Jason Gerberry
Bank of America Securities
Buy
Reiterated
$77.00
+35.6%
03/09/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$55.00
-3.1%
02/26/2026
Rudy Li
Wolfe Research
Buy
Initiated
$60.00
+5.7%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
74.98M
77.05M
87.70M
88.51M
Cost of revenue
74.98M
77.05M
87.70M
88.51M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.24M
19.28M
22.07M
23.82M
Operating expense
19.24M
19.28M
22.07M
23.82M
Total operating expenses
94.23M
96.34M
109.77M
112.33M
Operating income
-94.23M
-96.34M
-109.77M
-112.33M
Other non operating income
-
-
-
-
EBT including unusual items
-85.33M
-90.22M
-104.72M
-104.87M
EBT excluding unusual items
-85.33M
-90.22M
-104.72M
-104.87M
Income tax expense
-626.00K
677.00K
538.00K
-2.57M
Effective tax rate
0.73%
-0.75%
-0.51%
2.45%
Other operating expenses
-
-
-
-
Net income
-84.71M
-90.90M
-105.26M
-102.30M
Net profit margin
-
-
-
-
Earnings per share
-1.07
-1.15
-1.31
-1.17
Interest and investment income
7.20M
6.21M
5.34M
6.91M
Interest expense
-
-
-
-
Net interest expenses
7.20M
6.21M
5.34M
6.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-93.60M
-95.70M
-109.16M
-111.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of XENE
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer